CHICAGO, May 23, 2024 — Dream Exchange, the first minority-controlled stock exchange in the United States, is thrilled to announce that Harvey Catchings, a former NBA player and successful entrepreneur, has joined as an investor. 
Harvey Catchings has an impressive career spanning over four decades. After being drafted by the Philadelphia 76ers in 1974, Mr. Catchings enjoyed an 11-year NBA career before transitioning into the business world. Mr. Catchings’ entrepreneurial spirit and commitment to excellence have made him a respected figure in the Chicago business community. His career continued in Houston, Texas, where he pursued numerous sales opportunities in the mortgage and real estate development industry, he also advanced to a Business Manager role in the restaurant industry, and eventually transitioned into the reverse mortgage sector.

When asked about his decision to invest in Dream Exchange, Mr. Catchings shared, “The idea of starting a minority-led stock exchange, comparable to giants like NASDAQ and the American Stock Exchange, is not only historical but thrilling. Dream Exchange is particularly promising due to its expansive growth potential and a deeply fulfilling step towards building a legacy. I encourage all to consider the Dream Exchange seriously, as it offers a chance to generate wealth that can span across several generations.”

Joe Cecala Founder and CEO of Dream Exchange, expressed his enthusiasm, stating, “We are thrilled to welcome another visionary investor into our community, further strengthening our resolve to expand the financial landscape for entrepreneurs of all backgrounds. Mr. Catchings shares our unwavering belief that we can create a more equitable and prosperous future for all through the power of our public capital markets.”

About Dream Exchange

The Dream Exchange is preparing its application and operations to become the first minority-controlled company to operate a licensed stock exchange in the history of the United States. In addition, Dream Exchange is championing the creation of a new type of stock exchange called a venture exchange, which will list and trade the securities of smaller, early-stage companies. Dream Exchange’s mission is to create equal access to a marketplace that instills ethics, humanity, and fairness into finance.

Visit our website and follow us on LinkedIn for more.

MEDIA CONTACT
Vanessa Jean-Louis
Vice President of Public Relations
1-773-914-1182

SOURCE Dream Exchange

GOTHENBURG, Sweden, May 23, 2024 — ZeroPoint Technologies AB today closed a EUR 5.0 million Series A, led by European Deep Tech fund Matterwave Ventures. Additionally, Nordic Deep Tech fund Industrifonden served as the local lead for this round. Other existing investors participating include Climentum Capital and Chalmers Ventures. The new capital will be used to scale sales of existing products, bring additional hardware-accelerated memory products to market, and grow the company’s existing teams in Sweden and the United States.

“ZeroPoint Technologies’ customers include some of the biggest semiconductor companies in the world and our products are in demand by data center operators looking to overcome the mounting challenge of memory bottlenecks,” said Klas Moreau, CEO of ZeroPoint Technologies. “In fact, leading hyperscalers, such as Meta and Google, are now specifically calling for hardware-based compression technologies related to CXL-connected memory.”

“We are thrilled to back ZeroPoint Technologies and its world-class team on their mission. Their sophisticated memory compression and compaction technology has immense potential to improve performance and resource efficiency across many categories of devices. We have been impressed by the ZeroPoint team’s ability to engage with industry leaders and are excited to support their further growth and impact,” said Silviu Apostu, principal at Matterwave Ventures.”

“Industrifonden has proudly supported ZeroPoint Technologies over the last three years and we are pleased to continue that support as they accelerate through commercialization,” said Tobias Elmquist, senior investment director at Industrifonden. “With market trends such as the rapid expansion of AI, we believe that the memory bottleneck issue is more urgent today than when we made our initial investment in ZeroPoint.”

Typically, up to 70% of data stored is redundant. ZeroPoint’s products dramatically reduce that waste, which frees up memory capacity and increases bandwidth. This is accomplished by the company’s first of its kind hardware-accelerated compression and compaction solution. It combines lossless ultra-fast data compression with real-time data compaction and transparent memory management.

Given the exponentially increasing memory demands of today’s applications, partially driven by the explosive growth of generative AI, ZeroPoint addresses the critical need of today’s hyperscale and enterprise data center operators to get the most performance and capacity possible from increasingly expensive memory. ZeroPoint’s solutions are proven to increase memory capacity by 2-4x while also delivering up to 50% more performance per watt. In combination, these two effects can reduce the total cost of ownership of data center servers by up to 25%.

ZeroPoint’s technology is 1,000x faster than other compression technologies on the market, which allows ZeroPoint to compress data across the entire memory hierarchy – all the way from Cache to Storage. ZeroPoint’s technology is agnostic to data load, processor type, architectures, memory technologies and processing node, and the company’s IP has already been proven on a TSMC 5nm node.

About ZeroPoint Technologies AB

ZeroPoint Technologies is a spinout from Chalmers University of Technology in Gothenburg, Sweden, and has over the years developed an impressive IP Portfolio in the memory compression domain. Their patented compression technology is based on 15 years of research. The company was founded by Professor Per Stenström and Dr. Angelos Arelakis, with the vision to deliver the most efficient memory compression available, in real-time, based on state-of-the-art research. Today the company works with industry leaders on product implementation projects and technical evaluations. In April 2024, ZeroPoint joined the Intel Ignite global startup accelerator program for early-stage deep tech startups.

About Matterwave

Matterwave Ventures is a Munich-based venture capital firm specialized in deep tech innovations with industrial applications and investing throughout Europe. Matterwave focuses on the early development stages of technology companies, including hardware- and software-based business models. The goal is to back world-leading companies that drive the future of industrial value creation. Matterwave invests “full stack”, from materials and components to complete systems and software solutions. Over the past 20+ years, the team has invested in more than 60 companies. With over EUR 200 million of capital under management, Matterwave typically participates in Seed and Series A financing rounds across Europe with initial investments of up to EUR 4 million. 

About Industrifonden

Industrifonden is Sweden’s Venture Capital Fund looking for unique, scalable innovation that has a meaningful impact on our society. Industrifonden manages more than SEK 5 billion and invests in early-stage companies, from seed to A-round funding with a reach across the Nordics. The investment focus includes specialized technologies and businesses within Deep Tech, Life Science, and Transformative Tech. Industrifonden has an evergreen structure that allows a long-term focus on value creation. Learn more at industrifonden.com.

Logo – https://mma.prnewswire.com/media/2419475/ZeroPoint_Logo.jpg

SOURCE ZeroPoint Technologies AB

Brings Total Series B Funds Raised to Nearly $100 Million

Proceeds to Support Broadening Scope of Ongoing Clinical Trial of GRWD5769; First Clinical Data to be Reported at ASCO 2024

Company to Expand R&D Efforts to Develop Disease-Modifying Therapies for Autoimmune Disorders

OXFORD, UK, May 23, 2024 — Grey Wolf Therapeutics (“Grey Wolf” or “the company”), a clinical-stage biotechnology company leveraging first-of-its-kind antigen modulation therapies to address the source of immune dysfunction in oncology and autoimmunity, today announced the closing of an oversubscribed $50 million Series B financing expansion, bringing the total amount of Series B funds raised to $99 million. The Series B expansion round was led by ICG’s Life Sciences team and included further investment from existing investors Pfizer Ventures, Andera Partners, Canaan, Earlybird Venture Capital, Oxford Science Enterprises and British Patient Capital. Proceeds from the round will be leveraged to broaden the scope of the company’s ongoing Phase 1/2 clinical trial of its lead immuno-oncology candidate, GRWD5769, in a range of solid tumour types. The funding also enables the company to expand research and development (R&D) for its versatile antigen modulation approach into treatments for autoimmune disease indications.

“The funds raised as part of this Series B expansion round allows us to enrich our ongoing clinical trial of GRWD5769 to include patients with a wider variety of tumour types and evaluate new combination treatment cohorts. In addition, the new capital enables us to more fully explore the breadth of potential therapeutic applications for our antigen modulation technology,” said Peter Joyce, Ph.D., chief executive officer of Grey Wolf Therapeutics. “There is a wealth of supportive recent clinical research and compelling human genetic associations pointing to the potential for antigen modulation driven by ERAP inhibition to open the door for disease-modifying therapies in the field of autoimmune disease. As such, we are expanding our R&D efforts and evaluating these broader therapeutic applications for our unique technology.”

Initial data on the ongoing adaptive Phase 1/2 trial of the lead asset GRWD5769, a first-in-class ERAP1 inhibitor will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) annual meeting. A second ERAP1 inhibitor focussed on autoimmune disease is being advanced through IND-enabling studies with the goal of entering the clinic in 2025.

Tracy Weightman, Associate Director, Life Sciences at ICG, added, “Grey Wolf is an exciting growth stage UK biotechnology company with a novel and differentiated approach that has the potential to transform the lives of millions of patients globally. This investment demonstrates our commitment to building leading biotechnology companies and enabling them to compete on a global stage. We are pleased to support Grey Wolf through the next stage of its growth journey, enabling the company to advance its clinical development strategy and expand into new therapeutic areas.”

In conjunction with the financing, Grey Wolf has announced that Ms. Weightman has been appointed to the company’s board of directors.

About ERAP Inhibition
Grey Wolf has developed and is advancing a unique therapeutic strategy that leverages the ability to effectively modulate the presentation of target antigens to the human immune system to upregulate or downregulate immune cell activity for specific therapeutic outcomes. This is achieved through the targeted inhibition of the endoplasmic reticulum aminopeptidases (ERAP1 or ERAP2), proteins that play a key role in the antigen presentation pathway. In cancer, inhibiting ERAP1 or ERAP2 drives the generation and presentation of novel and potent antigens to elicit targeted immune activity. Additionally, this mechanism works to block the production of disease-causing auto-antigens to prevent pathogenic immune responses that drive autoimmune diseases.

About Grey Wolf Therapeutics
Grey Wolf Therapeutics is a clinical-stage, UK- and Australian-based drug discovery and development biotechnology company spearheading a new therapeutic approach based on a first-of-its-kind antigen modulation platform. The company’s lead clinical development candidate, GRWD5769, is a potent and selective oral ERAP1 inhibitor that has shown the potential to elicit a powerful and differentiated immune response against tumours. A second ERAP1 inhibitor, GRWD0715, is advancing through preclinical development as a potential treatment for autoimmune disease. The company is also leveraging its leadership in neoantigen creation with an ERAP2 drug discovery program and by therapeutically targeting novel ERAP1 inhibitor generated cancer antigens with MHC Class I directed therapies, such as soluble T cell receptor (TCR) and TCR mimic bispecifics.

For more information, please visit: www.gwt.bio

About ICG
ICG provides flexible capital solutions to help companies develop and grow. We are a leading global alternative asset manager with a 35-year history, managing $86.3bn of assets* and investing across the capital structure. We operate across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credit.

ICG develops long-term relationships with its business partners to deliver value for shareholders, clients and employees, and uses its position of influence to benefit the environment and society. ICG is committed to being a net zero asset manager across our operations and relevant investments by 2040.

ICG is a member of the FTSE 100 and listed on the London Stock Exchange (ticker symbol: ICG). Further details are available at www.icgam.com. You can follow ICG on LinkedIn, X (Twitter) and Instagram.

*as at 31 December 2023

Contacts:
Grey Wolf Therapeutics
Peter Joyce, CEO
+44 (0) 01235 644 970
[email protected]

Vida Strategic Partners (on behalf of Grey Wolf)
Tim Brons (media)
415-675-7402
[email protected]

ICG
Catherine Armstrong
Interim Head of Corporate Communications
+44 20 3545 1850
[email protected]

SOURCE Grey Wolf Therapeutics

SAN JOSE, Calif., May 23, 2024 — Startup World Cup is back in Silicon Valley! The Silicon Valley Regional Competition is scheduled for August 1st, 2024, at the Computer History Museum in Mountain View, CA.

Startup World Cup is looking for the best and the brightest startups to apply to compete. The selected Top 15 applicants will present on stage on August 1st. The winner of this event will join the 75+ other global finalists at the Startup World Cup Grand Finale series, in which they will have the opportunity to win a $1,000,000 investment prize in San Francisco on October 4th, 2024.

Startup World Cup 2024 Silicon Valley Regional: Apply and Win $1 Million Investment Prize
Startups apply here: https://www.startupworldcup.io/silicon-valley-app-2024

The application deadline is June 30! Do not miss your chance!

For more details on the Silicon Valley Regional event: https://www.startupworldcup.io/silicon-valley-regional. Check out the 2023 Silicon Valley Highlights Video.

Register for the event here.

Here are the Judges and Speakers confirmed to attend:

• Jihong Kim (Managing Director at Samsung Ventures)
• Rashmi Gopinath (General Partner at B Capital Group) 
• Abhishek Shukla (Managing Director at Prosperity7 Ventures)
• Arpan Shan (Partner at Pear VC)
• Nuno Goncalves Pedro (Founder and Managing Partner at Chamaeleon)
• Holly Wu (North America Tech M&A, Venture and Partnerships at Mercedes-Benz)
• Eric Rosenblum (Managing Partner at Foothill Ventures)
• Bill Reichert (Partner at Pegasus Tech Ventures)
• And others!

The Silicon Valley Regional Competition is part of the Startup World Cup global competition, with regional events in 75+ cities around the world, including thousands of entrepreneurs and hundreds of investors. The mission of Startup World Cup is to highlight the best technology startups around the world, and to connect those startups into the global innovation ecosystem.

Entrepreneurs who are not in the Silicon Valley region should check out regional competitions in their part of the world and the Series of Grand Finale events here: https://www.startupworldcup.io/grand-finale.

Worldwide Regional Competitions: https://www.startupworldcup.io/

About Pegasus Tech Ventures
Pegasus Tech Ventures is a global venture capital firm based in Silicon Valley with $2 Billion in assets under management. Pegasus offers intellectual and financial capital to emerging technology companies around the world. In addition to offering institutional investors a top-tier venture capital investment approach, Pegasus also offers a unique Venture Capital-as-a-Service (VCaaS) model for large, global corporations that wish to partner with cutting-edge technology startups. For more information about Pegasus, please check out https://www.pegasustechventures.com.

SOURCE Pegasus Tech Ventures

SINGAPORE, May 23, 2024 — With a commitment to broadening the reach and usability of blockchain technologies, HTX Ventures, the global investment arm of the cryptocurrency exchange HTX, has announced a strategic investment in Kelp DAO, a triple-income re-pledge protocol based on EigenLayer.

Kelp DAO has secured $9 million in its latest round of strategic private sales, which will support its vision to reshape the DeFi and restaking ecosystem. This funding will enable Kelp DAO to further develop its cutting-edge technology, expand its offerings, and refine its liquid restaking solutions. Currently, Kelp offers liquid restaking across the Ethereum mainnet and nine Layer 2 solutions, including Arbitrum, Blast, Linea, Base, and Scroll.

“We are excited to support Kelp DAO,” said Edward, Managing Partner at HTX Ventures. “Their focus on enhancing user experience and driving developer experimentation is pivotal to the early success of restaking. We believe Kelp’s innovative approach will transform the DeFi landscape, and we are thrilled to be part of their journey.”

Dheeraj Borra, Co-founder at Kelp, shared, “This fundraise not only fuels our operational capabilities but also validates the vision we have for Kelp, which is now shared by our investors. We’re excited to scale our solutions and enhance user experience even further with their support.”

HTX Ventures is thrilled to support innovative projects like Kelp DAO, which offers a much-needed, user-friendly, and scalable solution. Users can stay connected with Kelp DAO through their official website and social media channels for the latest product updates.

About HTX Ventures

HTX Ventures, the global investment division of HTX, integrates investment, incubation, and research to identify the best and brightest teams worldwide. With a decade-long history as an industry pioneer, HTX Ventures excels at identifying cutting-edge technologies and emerging business models within the sector. To foster growth within the blockchain ecosystem, we provide comprehensive support to projects, including financing, resources, and strategic advice.

HTX Ventures currently backs over 200 projects spanning multiple blockchain sectors, with select high-quality initiatives already trading on the HTX exchange. Furthermore, as one of the most active Fund of Funds (FOF) investors, HTX Ventures collaboratively forges the blockchain ecosystem alongside premier global blockchain funds, including Figment Capital, Dragonfly, Bankless Ventures, Animoca, Shima, and IVC.

Contact Details
Michael Wang
[email protected]

Company Website
https://www.htx.com/en-us/ventures

SOURCE HTX

SHANGHAI, May 23, 2024 — Qiming Venture Partners, a global-leading venture capital firm, is pleased to announce the promotion of Alex Zhou to Managing Partner.

As a Qiming home-grown Managing Partner, Alex first joined the firm in 2014 as a Vice President and has since emerged as one of the most active investors in frontier technologies, especially in the field of artificial intelligence. Alex will join fellow Managing Partners Duane Kuang, Nisa Leung and William Hu in managing Qiming’s operations.

In the past few years, Alex has actively participated in or led investments in many outstanding technology companies across the artificial intelligence, robotics, semiconductors, new energy vehicles, and software sectors. Notable among these include Roborock, UBTech, Unisound, Biren Technology, ROX Motor, VIEWTRIX Technology, Zhipu AI, Mech-Mind Robotics, Axera, HyperStrong, DeepWay, etc.

“I am deeply grateful for the guidance and trust I received from Qiming over the past 10 years.” Alex said. “We are at the forefront of a new wave of technological revolution. This era will undoubtedly bring about many bold innovators who will shape the future. Together with all the Managing Partners and colleagues at Qiming, I am excited and fully committed to seize the opportunities, embrace any potential challenges, explore new possibilities and build a better Qiming.”

Since its inception 18 years ago, Qiming has always committed to upgrading its institutional capabilities and team development in order to stay ahead in an ever-evolving technological and market landscape. The success achieved in the fields of healthcare, mobile internet and frontier technology is a testament to this strategic approach. Alex’s promotion to the most senior position in the firm demonstrates Qiming’s continued confidence in the future of technology innovation.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, UBTech, Yuanxin Technology, Caidya, Belief BioMed, WeRide, among many others.

The Investment Anchors $50 Million VVC Veterans Fund II

TYSONS, Va., May 22, 2024 — Veteran Ventures Capital (VVC) has secured a significant $10 million institutional investment from the Virginia Innovation Partnership Corporation (VIPC). This investment fuels VVC’s Veterans Fund II, anchoring a first closing towards the Fund’s $50 million target. Veteran Ventures, an early-stage venture capital firm, invests its capital alongside its partners’ contributions of expertise, network, and energy in support of veteran-led businesses developing innovative dual-use national security technologies. Virginia’s investment into Veteran Ventures Capital is specifically targeted at improving access to capital for veteran-led companies within the Commonwealth of Virginia.

Virginia offers a terrific ecosystem for technology and entrepreneurship. With access to top-tier veteran talent, proximity to government agencies, a strong network of tech-transfer initiatives and other strategic partnerships, and a dynamic business environment, Virginia provides a powerful ecosystem to support veteran entrepreneurs building national security-aligned technology companies. Governor Youngkin has often said he wants Virginia to be the best state for military families, veterans, and retirees to live, work and raise a family. Veteran Ventures Capital also aspires to add to that list the best state for veterans to found and build a business.  Veterans account for over 10% of the adult population in the state, making Virginia one of the highest concentrations of veterans in the U.S. Further, according to U.S. Small Business Administration data, there are nearly 75,000 veteran owned small business in Virginia.

“We are thrilled to announce Virginia’s investment in our second fund, marking a significant leap forward in our mission to empower veteran entrepreneurs and accelerate technological innovation and national security capabilities,” stated Derren Burrell, Founder and Managing Partner of Veteran Ventures Capital. “This achievement provides further evidence of the confidence and support our investors place in Veteran Ventures’ vision, the exceptional potential of veteran business leaders, and the firm’s investment track record in our first fund.”

“VIPC is excited to partner with Veteran Ventures Capital to catalyze and leverage significant private investment into Virginia’s veteran-led startups and entrepreneurs. We welcome VVC’s new HQ move into Virginia and look forward to VVC’s engagement with veteran communities throughout the commonwealth,” said Joe Benevento, President and CEO of VIPC. The investment is part of a $175 million ten-year program administered by VIPC with funds provided by the U.S. Treasury State Small Business Credit Initiative.

As the largest defense budget in history unfolds and global tensions escalate, institutional investors are showing unprecedented interest in aerospace and defense technology funds. The principals at Veteran Ventures Capital lead at the forefront of this dynamic technology and investment landscape. What distinguishes the team is their collective experience earned over decades operating start-ups and large companies in or around the national security landscape. The firm is uniquely positioned to navigate the complexities of this evolving sector. Notably, their Fund I portfolio companies have secured over $130 million in non-dilutive government funding to date, magnifying the impact of their deployed investor capital and helping to further fund their early-stage companies.

Building upon the momentum of their recently announced relocation to the firm’s new headquarters in Tysons, Virginia, Veteran Ventures Capital is well positioned for further expansion and investment. This move solidifies their commitment to actively contribute to defense industry modernization and to fund veteran leaders and entrepreneurs in the heart of the national security technology sector.

Since its inception in 2019, Veteran Ventures Capital has demonstrated a commitment to empowering veteran leaders and entrepreneurs nationwide. The firm’s dual-use national security technology focus leads them to invest in the most promising space, autonomy and robotics, advanced materials science, cyber security, quantum tech, artificial intelligence, and machine-learning technology companies in the nation. The team continues to leverage its extensive national security industry experience to shape the leading veteran-led technology companies of the future.

As Veteran Ventures Capital raises its second fund finalizing its first close this month, they remain dedicated to delivering exceptional value to investors while championing the transformative potential of veteran leadership in innovative national security technology companies.

About Veteran Ventures Capital:

Veteran Ventures Capital is a veteran-owned growth-equity investment firm empowering veteran entrepreneurs and leaders working at the nexus of national security and commercial technology. Their team invests exclusively in companies that have military veteran leadership; recognizing their military experience, training, and unwavering character translates into exceptional business acumen and superior risk-adjusted returns for investors.

Founded in 2019, Veteran Ventures Capital is now headquartered in Tysons, Virginia, and remains committed to empowering veteran entrepreneurs nationwide and leveraging the team’s extraordinary national security industry experience to shape the leading veteran-led commercial tech companies of the future. Veteran Ventures Capital is now actively raising its second fund with a target of $50 million.

For media inquiries, please contact:
Craig Jaques
Principal, Veteran Ventures Capital
Email: [email protected]
Phone: (808) 639-5300

SOURCE Veteran Ventures Capital

TORONTO, May 22, 2024 — Sinn Studio Inc., a renowned XR studio is thrilled to announce the successful closure of a $2.5 million funding round. This investment propels the studio into the development of the world’s first real-time Player vs Player (PvP) VR combat game, leveraging groundbreaking spatial computing technologies.

Fueled by a distinguished group of investors led by Hartmann Capital, with contributions from Boost VC, Republic, Alumni Ventures, Mana Ventures, MetaVision, and a number of industry angels such as Chris Ye of Uken Games, Sinn Studio is set to revolutionize the multiplayer combat genre.

The forthcoming free-to-play title is driven by Sinn Studio’s proprietary “Combat Engine” and is supported by the innovative “Large Intent Model” (LIM), a neural network specially designed to discern and learn from the intricate subtleties of human motion during combat. This development marks a significant leap forward, solving some of the industry’s most complex challenges in spatial computing.

Alek Sinn, Co-Founder & CEO of Sinn Studio Inc., expressed his enthusiasm and gratitude: “We spent seven years surviving the ups and downs of VR as a bootstrapped company, waiting for that industry-defining moment, and the right partners to commit to our first fundraise. Today, we’re incredibly grateful to Hartmann Capital and everyone else who joined our seed round for their belief in our mission to redefine the future of combat in this exciting new era of spatial computing. The technology we’re building will power incredible first-party combat experiences, and one day, our favourite IPs.”

Felix Hartmann, Managing Partner of Hartmann Capital, who has joined the Sinn Studio Board, shares the team’s vision, “Virtual Reality transforms experiences beyond the capabilities of traditional 2D screens. Combat, both a fundamental aspect of human competition and one of its oldest sports, is poised for a groundbreaking evolution in VR. Sinn Studio is at the forefront of this transformation and is setting the stage for immersive combat to become a pivotal part of both sports and cultural landscapes.”

Sinn Studio has captured the attention of the gaming community with its award-winning and best-selling title, Swordsman, acclaimed as a “Most Popular Game” of 2023 on Quest and a top 10 best seller on PlayStation VR. The studio, which started with a single developer in 2017, now boasts a full-time team of 30 and is poised for further success with its innovative approach to single-player and multiplayer melee combat.

The launch of their PvP combat game heralds a new chapter in the evolution of virtual reality gaming, blending the inherent fun of social interaction with the competitive spirit of combat. Sinn Studio is committed to offering gamers an unparalleled experience, setting a new standard for engagement and realism in the VR space.

For press inquiries, please contact:

[email protected]

About Sinn Studio Inc.

Sinn Studio Inc. is a premier XR studio based in Toronto, Canada, specializing in developing virtual reality combat experiences. With a focus on innovation and quality, Sinn Studio aims to push the boundaries of VR gaming, delivering immersive and interactive content that sets new industry standards. Learn more at sinnstudio.com

About Hartmann Capital

Hartmann Capital is a frontier tech investment firm covering Crypto, XR, Gaming, and AI. Its VC arm, Hartmann Metaverse Ventures, is an early stage venture fund series, which aims to secure significant positions within the burgeoning spatial web, particularly within the realms of gaming and virtual worlds.

Learn more at hartmanncapital.com

SOURCE Hartmann Capital

The Funding Round, led by PeakSpan Capital, will Accelerate Investments in Key Areas, Including Global Sales Infrastructure, Product Innovation, and AI-enabled Workflows.

NEWARK, Del., May 22, 2024 — SOCRadar, a leading provider of enterprise-grade, end-to-end threat intelligence and brand protection, today announced the successful completion of its Series B funding round, raising $25.2 million. The round was led by PeakSpan Capital, with participation from Oxx, reflecting investor confidence in SOCRadar’s innovative approach to cybersecurity.

External cybersecurity has rapidly escalated in criticality since the onset of the pandemic, fueled by unparalleled levels of digital transformation, cloud migrations, and increased levels of remote work. According to Verizon’s DBIR 2023 Report, 83% of respondents cited external threats as the number one cause of cyber threats, with ransomware, Business Email Compromise (BEC), and phishing leading the way. As supporting evidence, the FBI’s Internet Crime Report 2023 shows that phishing is the number one cause of complaint count, and BEC is the second highest in complaint loss. What is more concerning is that at the current growth rate, financial damage from cyberattacks will amount to about $10.5T annually by 2025 – a 300% increase from 2015.

SOCRadar is dedicated to delivering pre-emptive defense against cyber threats, such as ransomware, phishing, and BEC, as well as all externally sourced attacks, and, most importantly, to detect and prevent attacks before they happen.

“Our main mission is to provide proactive protection against external cyber threats for companies of all sizes,” said Huzeyfe Onal, CEO of SOCRadar. This investment will help us continue to expand in key geographies and further bolster our AI capabilities across our platform.

SOCRadar’s innovative go-to-market strategy focuses on product-led growth and sales, successfully reaching and engaging customers globally. The company has reached over 25,000 freemium customers from 150+ countries worldwide and boasts 600+ active paid customers alongside 350+ channel partners. This global adoption is a testament to the shared problem faced by all companies worldwide and the effectiveness of SOCRadar’s solution in addressing external cybersecurity needs.

SOCRadar’s flagship product, the Extended Threat Intelligence (XTI) cloud-based SaaS platform, offers an end-to-end suite of external cybersecurity solutions, including Cyber Threat Intelligence, External Attack Surface Management, Brand Protection, Dark Web Monitoring, and Supply Chain Threat Intelligence. Cost-effective, natively unified, and easy to use, SOCRadar’s platform empowers organizations to proactively defend against all primary external breach vectors.

The funds raised in the Series B round will primarily be used to drive the company’s expansion in the US market, invest in the EU market to strengthen the company’s strong presence in the region, continue to penetrate the Managed Service Provider (MSP) and Managed Security Services Provider (MSSP) markets and invest in research and development. Specifically, SOCRadar will continue to utilize artificial intelligence (AI) across all aspects of its platform to enhance threat detection, response, and automated remediation capabilities.

“We are excited to partner with Huzeyfe, Ahmet, and the entire SOCRadar team in their pursuit of democratizing external threat intelligence for enterprises and mid-market organizations globally,” said Sanket Merchant, Partner at PeakSpan Capital. “The team is attacking arguably one of the most strategic challenges in cybersecurity today, which is only growing in criticality, with exceptional product innovation/leadership and a compelling, high-velocity value proposition that is truly differentiated. We see an incredible opportunity for SOCRadar to emerge as the leading global provider of external cybersecurity for a strategic (and underserved) market segment and couldn’t be more privileged to be their partner navigating this next stage of their scale-up journey.”

Richard Anton, Co-Founder and General Partner at Oxx, continues, “We’re delighted to join forces with US-based investor PeakSpan and early investor 212 as we partner with SOCRadar. As an international European investor, we look forward to providing SOCRadar with the best support possible as they accelerate their global go-to-market strategy. We are committed to supporting SOCRadar’s expansion in Europe.”

With this latest round of funding, SOCRadar is poised to further strengthen its position as a trusted partner for organizations seeking to defend against external cyber threats and safeguard their digital assets.

About SOCRadar

SOCRadar is a pioneering cybersecurity company committed to delivering advanced threat intelligence solutions that enable organizations to proactively defend against cyber threats. SOCRadar’s flagship Extended Threat Intelligence (XTI) platform offers a comprehensive suite of tailored products. These are Cyber Threat Intelligence, External Attack Surface Management, Brand Protection, Dark Web Monitoring, and Supply Chain Threat Intelligence. By harnessing the power of artificial intelligence and machine learning, SOCRadar enhances threat detection capabilities and promptly provides proactive and actionable intelligence. ensuring that businesses can always stay ahead of cyber risks. With a significant global footprint. SOCRadar’s mission is to fortify organizational defenses, mitigate external risks, and foster a safer digital ecosystem worldwide.

About PeakSpan Capital

PeakSpan Capital is a growth equity firm based in New York City and San Mateo. Having partnered with over 40 high-growth software businesses and with $1.5B+ in AUM, PeakSpan’s mission is to be the partner of choice for growth-stage entrepreneurial teams who are building amazing software targeted at business buyers of all sizes. PeakSpan combines deep domain expertise within a select number of themes with a proprietary technology platform providing visibility into company and market performance to help disruptive entrepreneurs drive resilient, risk-adjusted value creation.

To learn more about PeakSpan Capital and its portfolio, please visit www.peakspancapital.com. 

About Oxx

Oxx partners with the most promising B2B software companies at the scale-up stage. As a specialist SaaS investor, Oxx’s strategy is built around the concept of “Go-To-Market Fit,” developing a structure for thinking about how to build a repeatable, sustainable growth engine that accelerates and propels the growth of SaaS companies.

Oxx was founded by Richard Anton and Mikael Johnsson in 2017 and is headquartered in London and Stockholm. For more information, visit oxx.vc

For further information, please contact:

Burak Uyduran
Email: [email protected]

Logo – https://mma.prnewswire.com/media/2417412/SOCRadar_Logo.jpg